China Dasheng Biotechnology Company
CDBT · OTC
12/31/2024 | 9/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $15 | $7 | $0 | $7 |
| Gross Profit | -$15 | -$7 | $0 | -$7 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $59 | $34 | $34 | $81 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $59 | $34 | $34 | $81 |
| Operating Income | -$74 | -$41 | -$34 | -$87 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | -$73 | -$46 |
| Pre-Tax Income | -$74 | -$41 | -$107 | -$134 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$74 | -$41 | -$107 | -$134 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.001 | -0.003 | -0.003 |
| % Growth | -80% | 61.5% | 21.2% | – |
| EPS Diluted | -0.002 | -0.001 | -0.003 | -0.003 |
| Weighted Avg Shares Out | 40,976 | 40,976 | 40,976 | 40,976 |
| Weighted Avg Shares Out Dil | 40,976 | 40,976 | 40,976 | 40,976 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $5 | $61 |
| Depreciation & Amortization | $15 | $7 | $0 | $7 |
| EBITDA | -$59 | -$34 | -$102 | -$66 |
| % Margin | – | – | – | – |